FeesSafety
Pluang+

CoinShares sells $19.3M in Ethereum and Solana treasury to fund $40M share buyback program.

Market News
18 Nov 2026, 18:12 WIB
Crypto Economy
View Source
Bullish
CoinShares sells $19.3M in Ethereum and Solana treasury to fund $40M share buyback program.

CoinShares sold its entire corporate Ethereum treasury for $16.6 million and half its Solana treasury for $2.7 million in October to fund a share repurchase program authorized by its board. The $19.3 million crypto sale is part of a $40 million buyback plan, reflecting the board's view that repurchasing shares is a better use of capital than holding these crypto assets. This move affects only the corporate treasury assets, not the company's larger operational digital asset holdings or investment products. CoinShares continues to maintain significant digital asset exposure while reallocating some treasury funds toward equity buybacks, signaling a strategic shift in capital allocation.

CoinShares' recent treasury sales provide context for crypto market activity. For readers following major cryptocurrencies on Pluang, here is the market snapshot as of Nov 18, 2026 22:42 WIB: out of 50 priced assets, 12 rose and 37 fell. Notable movers include CRV at Rp3.679 with a 1-day change of -3.18% and a Pluang order activity of 73% Sell / 27% Buy, and COTI at Rp155 with a 1-day change of -2.99% and 91% Sell / 9% Buy activity.

More News

Global pharmaceutical market to hit $3.2T by 2035, led by obesity and cancer drug growth amid US tariff shifts

Global pharmaceutical market to hit $3.2T by 2035, led by obesity and cancer drug growth amid US tariff shifts

The global pharmaceutical market is projected to grow from $1.88 trillion in 2026 to $3.20 trillion by 2035, driven mainly by obesity and oncology drugs. The U.S. market, holding 42% of the global share, faces new tariffs linked to pricing deals and ...

Bullish
27 minutes ago
LEQEMBI slows Alzheimer's progression by 76% over 3 years in real-world study of 560 patients.

LEQEMBI slows Alzheimer's progression by 76% over 3 years in real-world study of 560 patients.

A new three-year real-world study of 560 early Alzheimer's patients treated with LEQEMBI showed a 76% reduction in progression to moderate or severe dementia compared to a matched control group. Over 81% of patients remained stable or improved after ...

Market News
Bullish
27 minutes ago
Fox Factory wins seventh straight Baja 1000 and sweeps 2026 SCORE off-road championships

Fox Factory wins seventh straight Baja 1000 and sweeps 2026 SCORE off-road championships

Fox Factory Holding Corp. celebrated its seventh consecutive overall victory at the 2026 SCORE Baja 1000, with FOX Shocks and Method Race Wheels powering the winning team. The company’s equipment helped athletes sweep all four 2026 SCORE Internationa...

Market News
Bullish
27 minutes ago
Global automotive actuators market to grow to $40.3B by 2033 driven by electrification and automation

Global automotive actuators market to grow to $40.3B by 2033 driven by electrification and automation

The global automotive actuators market, valued at $29.3 billion in 2025, is projected to grow to $40.3 billion by 2033 at a CAGR of 4.4%. Growth is fueled by rising electric vehicle production, advanced safety systems, and automation technologies. As...

Market News
Bullish
27 minutes ago
TJX Companies beats Q3 sales estimates; shares jump 10% on strong international growth and holiday optimism.

TJX Companies beats Q3 sales estimates; shares jump 10% on strong international growth and holiday optimism.

The TJX Companies reported Q3 FY2027 revenue of $16 billion, beating estimates with a 5.5-6% year-over-year increase. Comparable store sales grew 4%, led by strong international segment performance, while the domestic Marmaxx group showed slower grow...

Company Fundamentals
Bullish
30 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App